Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "anti cancer" wg kryterium: Temat


Wyświetlanie 1-14 z 14
Tytuł:
Role of mitochondria in carcinogenesis
Autorzy:
Tokarz, Paulina
Blasiak, Janusz
Powiązania:
https://bibliotekanauki.pl/articles/1039194.pdf
Data publikacji:
2014
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
cancer
mitochondria
mtDNA
ROS
anti-cancer therapy
Opis:
Mitochondria play the central role in supplying cells with ATP and are also the major source of reactive oxygen species (ROS) - molecules of both regulatory and destructive nature. Dysfunction of mitochondrial metabolism and/or morphology have been frequently reported in human cancers. This dysfunction can be associated with mitochondrial DNA (mtDNA) damage, which may be changed into mutations in mtDNA coding sequences, or the displacement-loop region, changes in the mtDNA copy number or mtDNA microsatellite instability. All these features are frequently associated with human cancers. Mutations in mtDNA can disturb the functioning of the ROS-producing organelle and further affect the entire cell which may contribute to genomic instability typical for cancer cells. Although the association between some mtDNA mutations and cancer is well established, the causative relationship between these two features is largely unknown. A hint suggesting the driving role of mtDNA mutations in carcinogenesis comes from the observation of tumor promotion after mtDNA depletion. Mitochondria with damaged DNA may alter signaling of the mitochondrial apoptosis pathway promoting cancer cell survival and conferring resistance to anticancer drugs. This resistance may be underlined by mtDNA copy number depletion. Therefore, mitochondria are considered a promising target in anticancer therapy and several mitochondria-targeting drugs are in preclinical and clinical trials. Some other aspects of mitochondrial structure and functions, including morphology and redox potential, can also be associated with cancer transformation and constitute new anticancer targets. Recently, several studies have disclosed new mechanisms underlying the association between mitochondria and cancer, including the protection of mtDNA by telomerase, suggesting new approaches in mitochondria-oriented anti-cancer therapy.
Źródło:
Acta Biochimica Polonica; 2014, 61, 4; 671-678
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
New benzimidazole derivatives with potential cytotoxic activity - study of their stability by RP-HPLC
Autorzy:
Błaszczak-Świątkiewicz, Katarzyna
Mirowski, Marek
Kaplińska, Katarzyna
Kruszyński, Rafał
Trzęsowska-Kruszyńska, Agata
Mikiciuk-Olasik, Elżbieta
Powiązania:
https://bibliotekanauki.pl/articles/1039749.pdf
Data publikacji:
2012
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
benzimidazole
hypoxia
RP-HPLC
nitrobenzimidazole
anti-cancer drugs
Opis:
Obtained benzimidazole derivatives, our next synthesized heterocyclic compounds, belong to a new group of chemical bondings with potential anticancer properties (Błaszczak-Świątkiewicz & Mikiciuk-Olasik, 2006, J Liguid Chrom Rel Tech 29: 2367-2385; Błaszczak-Świątkiewicz & Mikiciuk-Olasik, 2008, Wiad Chem 62: 11-12, in Polish; Błaszczak-Świątkiewicz & Mikiciuk-Olasik, 2011, J Liguid Chrom Rel Tech 34: 1901-1912). We used HPLC analysis to determine stability of these compounds in 0.2% DMSO (dimethyl sulfoxide). Optimisation of the chromatographic system and validation of the established analytical method were performed. Reversed phases (RP-18) and a 1:1 mixture of acetate buffer (pH 4.5) and acetonitrile as a mobile phase were used for all the analysed compounds at a flow rate 1.0 mL/min. The eluted compounds were monitored using a UV detector, the wavelength was specific for compounds 6 and 9 and compounds 7 and 10. The retention time was specific for all four compounds. The used method was found to have linearity in the concentration range of (0.1 mg/mL-0.1 μg/mL) with a correlation coefficient not less than r2=0.9995. Statistical validation of the method proved it to be a simple, highly precise and accurate way to determine the stability of benzimidazole derivatives in 0.2% DMSO. The recoveries of all four compounds examined were in the range 99.24-100.00%. The developed HPLC analysis revealed that the compounds studied remain homogeneous in 0.2% DMSO for up to 96 h and that the analysed N-oxide benzimidazole derivatives do not disintegrate into their analogues - benzimidazole derivatives. Compounds 8, 6 and 9 exhibit the best cytotoxic properties under normoxic conditions when tested against cells of human malignant melanoma WM 115.
Źródło:
Acta Biochimica Polonica; 2012, 59, 2; 279-288
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
miRNA Multiplayers in glioma. From bench to bedside
Autorzy:
Rolle, Katarzyna
Powiązania:
https://bibliotekanauki.pl/articles/1038962.pdf
Data publikacji:
2015
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
cancer
glioblastoma multiforme (GBM)
miRNA
anti-cancer therapy
diagnosis
prognosis
Opis:
Glioblastoma multiforme (GBM) is the most common type of malignant gliomas, characterized by genetic instability, intratumoral histopathological variability and unpredictable clinical behavior. Disappointing results in the treatment of gliomas with surgery, radiation and chemotherapy have fuelled a search for a new therapeutic targets and treatment modalities. A novel small non-coding RNA molecules, microRNAs (miRNAs), appear to represent one of the most attractive target molecules contributing to the pathogenesis of various types of tumors. They play crucial roles in tumorigenesis, angiogenesis, invasion and apoptosis. Some miRNAs are also associated with clinical outcome and chemo- and radiotherapy resistance. Moreover, miRNA have the potential to affect the responses to molecular-targeted therapies and they also might be associated with cancer stem cell properties, affecting tumor maintenance and progression. The expression profiles of miRNAs are also useful for subclassification of GBM, what underscores the heterogeneity of diseases that all share the same WHO histopathological grade. Importantly, molecular subtypes of GBM appear to correlate with clinical phenotypes, tumor characteristic and treatment outcomes. miRNAs are then biological markers with possible diagnostic and prognostic potential. They could also serve as one of the promising treatment targets in human glioblastoma.
Źródło:
Acta Biochimica Polonica; 2015, 62, 3; 353-365
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Aloe vera – wybrane właściwości biologiczne
Aloe vera – selected biological properties
Autorzy:
Matejczyk, M.
Golonko, A.
Chilmon, E.
Powiązania:
https://bibliotekanauki.pl/articles/403089.pdf
Data publikacji:
2017
Wydawca:
Politechnika Białostocka. Oficyna Wydawnicza Politechniki Białostockiej
Tematy:
Aloe vera
biologiczna aktywność
działanie antynowotworowe
biological activity
anti-cancer effect
Opis:
Aloes jako ludowy medykament o wszechstronnych właściwościach prozdrowotnych jest znany ludzkości od setek lat. Ekstrakty aloesowe cieszą się ogromnym zainteresowaniem farmakologów, medyków oraz kosmetologów. Wykazano, że poszczególne składniki żelu aloesowego są antyoksydantami, stymulantami aktywności układu immunologicznego, mają właściwości antynowotworowe, obniżające poziom cukru i lipidów we krwi, a także wpływają pozytywnie na gojenie się ran czy oparzeń i działają przeciwzapalnie. Ostatnio opublikowano kilka znaczących prac, w których wykazano silne właściwości antyrakowe wybranych składników aloesu. Stąd, amerykańska FDA (ang. Food and Drug Administration) poparła projekty badań naukowych dotyczących zastosowania A. vera w leczeniu raka i AIDS u ludzi. W prezentowanej pracy przedstawiono ogólny skład żelu aloesowego wraz z najbardziej aktywnymi biologicznie substancjami. Scharakteryzowano aktywność antyoksydacyjną i przeciwdrobnoustrojową Aloesu, potencjalne działanie antynowotworowe oraz przedstawiono wpływ żelu aloesowego na przewód pokarmowy człowieka, przemiany węglowodanów, układ immunologiczny i proces gojenia się ran.
Aloe as a folk medicine with comprehensive healthpromoting properties has been known to humanity for hundreds of years. Aloe extracts are very popular among pharmacologists, medics and cosmetologists. It was demonstrated that the individual components of the aloe gel are antioxidants, stimulants of the immune system, have anti-cancer properties, lower blood sugar and lipid levels, and have a positive effect on wound healing, burns and anti-inflammatory effects. Recently, several significant papers have been published in which strong anti-cancer properties of selected aloe components have been demonstrated. Hence, the American Food and Drug Administration (FDA) has endorsed scientific research on the use of A. vera in the treatment of cancer and AIDS in humans. In the presented review, the general properties of Aloe are discussed, biological activity and the potential anti-cancer activity of the main, most active components of this plant are presented.
Źródło:
Budownictwo i Inżynieria Środowiska; 2017, 8, 4; 191-195
2081-3279
Pojawia się w:
Budownictwo i Inżynieria Środowiska
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Dwa oblicza selenu. Wybrane aspekty aktywności biologicznej selenu
Two faces of selenium. Selected aspects of selenium biological activity
Autorzy:
Golonko, A.
Matejczyk, M.
Powiązania:
https://bibliotekanauki.pl/articles/402855.pdf
Data publikacji:
2018
Wydawca:
Politechnika Białostocka. Oficyna Wydawnicza Politechniki Białostockiej
Tematy:
selen
aktywność biologiczna
działanie antynowotworowe
selenium
biological activity
anti-cancer effect
Opis:
Badania ostatnich lat wskazują na bardzo cenne pod względem medycznym właściwości selenu. Zainteresowanie selenem wzrosło odkąd poznano metody jego oznaczania w materiale biologicznym i jego rolę w organizmach żywych. Selen w zależności od stężenia wykazuje właściwości antyoksydacyjne i prooksydacyjne. Ponadto w badaniach na zwierzętach oraz ludzkich i zwierzęcych liniach komórkowych wykazuje właściwości antynowotworowe. W dobie wzrostu zachorowalności na choroby nowotworowe, selen cieszy się dużym zainteresowaniem naukowców na całym świecie. Obecne wyniki badań wskazują na bardzo różnorodną aktywność biologiczną selenu. Jednym z głównych mechanizmów działania tego pierwiastka jest czynny udział w ochronie komórek przed skutkami stresu oksydacyjnego. W prezentowanej pracy przeglądowej omówiono ogólne właściwości selenu, zaprezentowano jego aktywność biologiczną i obecny stan wiedzy o jego potencjalnym działaniu antynowotworowym. Przedstawiono mechanizmy działania selenu na poziomie molekularnym.
Studies of recent years indicate the very valuable properties of selenium in medical field. The interest in selenium has increased since we learned the methods of its determination in biological samples and its role in living organisms. Selenium, depending on the concentration, has antioxidant and prooxidative properties. In addition, in animal studies and human and animal cell lines, it exhibits anti-cancer properties. In the era of increased incidence of human and animal cancer, selenium is very popular among scientists around the world due to its high biological activity. Current research results highlight the various effects of selenium molecular activity. One of the main mechanisms of action of this element is active participation in the protection of cells against the effects of oxidative stress. The review presents the general properties of selenium, its biological activity and the current state of knowledge about its potential anticancer activity. Also, known molecular mechanisms of selenium activity in a living cell are mentioned.
Źródło:
Budownictwo i Inżynieria Środowiska; 2018, 9, 2; 65-74
2081-3279
Pojawia się w:
Budownictwo i Inżynieria Środowiska
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Studies on some physical properties of pyrazolo-quinazolines
Autorzy:
Baluja, Shipra
Ramavat, Paras
Nandha, Kajal
Powiązania:
https://bibliotekanauki.pl/articles/1193021.pdf
Data publikacji:
2016
Wydawca:
Przedsiębiorstwo Wydawnictw Naukowych Darwin / Scientific Publishing House DARWIN
Tematy:
Conductance
DMF
DMSO
Density
Refractive Index
anti bacterial
anti cancer
anti fungal
anti inflammatory
anti viral
pyrazolo-quinazoline derivatives
Opis:
Some new pyrazolo-quinazoline derivatives have been synthesized and their characterization was done by IR, NMR and mass spectra. Further, some physicochemical properties such as density, refractive index, have been studied for these synthesized compounds, in different solvents at 298.15 K, 308.15 K and 318.15 K temperatures. Conductance has been studied for these synthesized compounds, in different solvents at 308.15 K.
Źródło:
World Scientific News; 2016, 29; 12-24
2392-2192
Pojawia się w:
World Scientific News
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Modyfikacje epigenetyczne jako potencjalne cele terapii antynowotworowych
Epigenetic modifications as potential targets of anti-cancer therapy
Autorzy:
Kulczycka, Anna
Bednarek, Ilona
Dzierżewicz, Zofia
Powiązania:
https://bibliotekanauki.pl/articles/1034844.pdf
Data publikacji:
2013
Wydawca:
Śląski Uniwersytet Medyczny w Katowicach
Tematy:
epigenetyka
dna
histony
metylacja
acetylacja
fosforylacja
terapie antynowotworowe
epigenetics
histones
methylation
acetylation
phosphorylation
anti-cancer treatments
Opis:
Epigenetics analyses inherited characteristics not directly connected to the DNA nucleotide sequence. It investigates the relationships between biochemical modifications and the expression of selected genes. Initially, it was thought that gene expression depends on information encoded in the DNA sequence. However, it was discovered that the activity of many enzymes like methylases, demethylases, acetylases, deacetylases is necessary to regulate this process and its dysregulations may lead to e.g. cancer initiation and progression. Epigenetics has an impact on neoplastic transformation by reducing the global level of DNA methylation and increasing the methylation level within tumour suppressor gene promoters, which significantly impairs the repression of carcinogenesis. Additionally, modifications of histone proteins, based on disorders of acetylation-deacetylation and methylation-demethylation processes, may lead to overexpression of genes involved in cancer development. Numerous examples have been described, among others breast, prostate and colon cancers, depending on the modification of histone amino tails, primarily of histone H3. For such reasons, the possibility of using many therapies which can reverse the negative effect of these modifications by e.g. DNA demethylation (DNA demethylating drugs) or re-acetylation of histone lysine resides (histone deacetylase inhibitors) is examined. In the near future, epigenetics probably will allow the effective treatment of some cancer diseases, although further research on the impact of enzymatic modifications on the development of carcinogenesis is still needed.
Epigenetyka zajmuje się badaniem cech dziedzicznych, które nie zależą bezpośrednio od sekwencji nukleotydowej w DNA, ale są rezultatem modyfikacji biochemicznych na ekspresję wybranych genów. Początkowo uważano, że ekspresja genów zależy tylko od informacji zapisanej zawartej w sekwencji DNA, z czasem okazało się, że liczne modyfikacje będące rezultatem działania różnych grup enzymów, w tym metylaz, demetylaz, acetylaz czy deacetylaz, wpływają na regulację tego procesu, a zaburzenia regulacji aktywności tych enzymów mogą prowadzić do wystąpienia i rozwoju m.in. nowotworów. Epigenetyczny aspekt rozwoju transformacji nowotworowej wskazuje na obniżenie globalnego poziomu metylacji DNA oraz podwyższenie poziomu metylacji w obrębie promotorów genów supresorowych, co znacząco upośledza represję nowotworzenia. Dodatkowo, modyfikacje białek histonowych, opierające się na dysregulacji procesów acetylacji–deacetylacji i metylacji – demetylacji, prowadzą do nadekspresji genów zaangażowanych w rozwój kancerogenezy. Opisane zostały liczne przykłady zależności wystąpienia nowotworów, m.in. raka sutka, stercza czy okrężnicy od wystąpienia danej modyfikacji reszt aminokwasowych białek histonowych, w tym głównie histonu H3. Z takich też przyczyn podejmowane są próby zastosowania terapii odwracających negatywny skutek wybranych modyfikacji, np. poprzez demetylację DNA (leki demetylujące DNA) czy reacetylację reszt lizynowych histonów (inhibitory decetylaz histonów). W niedalekiej przyszłości epigenetyka najprawdopodobniej u możliwi skuteczne leczenie części chorób nowotworowych, aczkolwiek konieczne są dalsze badania wpływu modyfikacji enzymatycznych na mechanizm rozwoju kancerogenezy.
Źródło:
Annales Academiae Medicae Silesiensis; 2013, 67, 3; 201-208
1734-025X
Pojawia się w:
Annales Academiae Medicae Silesiensis
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Tumor Anti-Initiation and Anti-Progression Properties of Sulphated-Extract of Colocasia esculenta
Autorzy:
Gamal-Eldeen, Amira M.
Amer, Hassan
Fahmy, Cinderella A.
Dahlawi, Haytham
Elesawy, Basem H.
Faizo, Nahla L.
Raafat, Bassem M.
Powiązania:
https://bibliotekanauki.pl/articles/2015590.pdf
Data publikacji:
2021-12-01
Wydawca:
Instytut Rozrodu Zwierząt i Badań Żywności Polskiej Akademii Nauk w Olsztynie
Tematy:
Colocasia esculenta
CYP1A
cancer chemoprevention & tumor anti-initiating
HDAC
macrophage function
breast MCF-7 carcinoma
Opis:
Colocasia esculenta (Taro) is an edible tuberous plant; however, corms are its most worldwide consumed part while the corm powder is widely used in food industries. In this work, a sulphated polysaccharide extract of C. esculenta corm (SCE) was prepared and its cancer chemopreventive properties was explored. The amending of carcinogen metabolism and radical scavenging affinity revealed that SCE is a strong tumor anti-initiation agent via suppressing cytochrome P450-1A and enhancing glutathione and the carcinogen detoxification enzyme; glutathione S-transferase. SCE exhibited a strong scavenging affinity towards critical radicals (hydroxyl and peroxyl). It induced lymphocyte growth and modulated the macrophage functions into an anti-inflammatory profile, via elevating macrophage proliferation and its binding affinity of fluorescein isothiocyanate-lipopolysaccharide (FITC-LPS) and inhibiting nitric oxide and tumor necrosis factor-α generation. Furthermore, SCE showed a potent cytotoxicity against human breast MCF-7 carcinoma cells (IC50 27.73 µg/mL), whereas SCE treatment inhibited the activity of histone deacetylase (HDAC IC50 37.70 µg/mL) and disturbed the pattern of cell cycle phases. An arrest in both S- and G2/M-phases was linked with shifted cell populations towards late apoptosis and necrosis, as detected by flow cytometry. SCE is a promising cancer chemopreventive agent to be used in healthy food industries and for high breast cancer-risk population.
Źródło:
Polish Journal of Food and Nutrition Sciences; 2021, 71, 4; 393-401
1230-0322
2083-6007
Pojawia się w:
Polish Journal of Food and Nutrition Sciences
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
The role of enzalutamide in the treatment of prostate cancer from the perspective of Polish oncologists
Autorzy:
Bal, Wiesław
Gajda, Maksymilian
Powiązania:
https://bibliotekanauki.pl/articles/2159010.pdf
Data publikacji:
2022-06-30
Wydawca:
Medical Education
Tematy:
enzalutamide
prostate cancer
hormonotherapy
anti-androgen
second-generation an-
Opis:
For several years, prostate cancer has remained the most common malignancy in male patients in Poland. A large number of patients combined with rising costs of therapy translate into a significant socio-economic burden. In a clinical oncologist’s practice, we usually deal with patients with advanced prostate cancer. Taking into account the poorer prognosis in advanced disease, development of new therapeutic options as well we their adequate selection is of paramount importance. Enzalutamide is one of the second-generation androgen axis inhibitors, which has the ability to overcome resistance to androgen deprivation therapy by inhibiting the androgen-DNA signalling on several levels. Its efficacy and safety had been proven in numerous phase II and phase III clinical studies and it has been registered by regulatory authorities in the United States and European Union in the treatment of mCRPC, mCSPC and nmCRPC. In this article selected issues related to the treatment of prostate cancer are discussed, with particular emphasis on the role of enzalutamide (including its mechanism of action, indications, efficacy and safety).
Źródło:
OncoReview; 2022, 12, 2; 45-49
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Inula viscosa phenolic extract suppresses colon cancer cell proliferation and ulcerative colitis by modulating oxidative stress biomarkers
Autorzy:
Kheyar, Naoual
Bellik, Yuva
Serra, Ana Teresa
Kheyar, Farida
Bedjou, Fatiha
Powiązania:
https://bibliotekanauki.pl/articles/16648114.pdf
Data publikacji:
2022
Wydawca:
Polska Akademia Nauk. Czasopisma i Monografie PAN
Tematy:
Inula viscosa
ulcerative colitis
colorectal cancer
anti-inflammatory
antiproliferative
Opis:
Inula viscosa is a perennial herbaceous plant native to the Mediterranean Basin, which is used topically for the treatment of various diseases in folk medicine. This study aimed to evaluate the in vivo intestinal anti-inflammatory activity of the ethanolic extract of I. viscosa (EEIV) and to test its effect on a colorectal cancer cell line. EEIV was administered to rats orally and daily at 100 and 200 mg/kg body weight for 7 days, and then colitis was induced by intrarectal instillation of 2 ml of 4% (v/v) acetic acid (AA) solution. At the end of the experiment, clinical examinations of the rats were conducted by evaluating macroscopic and histological signs of colonic tissues and measuring erythrocyte sedimentation rate (ESR) and the levels of C-reactive protein, fibrinogen, myeloperoxidase (MPO), malondialdehyde (MDA) and nitric oxide (NO). Using MTS assay, the antiproliferative effect of EEIV against human colon carcinoma HT29 cells and cytotoxicity on nondifferentiated Caco-2 cell line was evaluated. EEIV significantly decreased the ESR and fibrinogen levels as compared to control colitic rats (P < 0.001). It also significantly decreased the NO, MDA, and MPO levels in the colon tissue compared with the untreated colitic group (P < 0.001). These results were confirmed by macroscopic and histological examination, which showed significant protection against AA-induced ulcerative colitis. Furthermore, EEIV at a concentration of 369.88 μg/ml did not show cytotoxicity on confluent Caco-2 cells, with significant inhibition of colorectal cancer cell (HT29) growth (EC50 = 62.39 μg/ml). These results demonstrate that EEIV plays a potential role as pharmacological tool in the management of inflammatory bowel disease and prevention of colorectal cancer.
Źródło:
BioTechnologia. Journal of Biotechnology Computational Biology and Bionanotechnology; 2022, 103, 3; 269-284
0860-7796
Pojawia się w:
BioTechnologia. Journal of Biotechnology Computational Biology and Bionanotechnology
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
HER2-positive breast cancer -a vailable anti-HER2 therapies and new agents under investigation
Autorzy:
Zielinska, M.
Zarankiewicz, N.
Kosz, K.
Kuchnicka, A.
Cisel, B.
Powiązania:
https://bibliotekanauki.pl/articles/2097840.pdf
Data publikacji:
2020
Wydawca:
Instytut Medycyny Wsi
Tematy:
breast cancer
targeted therapies
HER2-positive breast cancer
HER2-targeting treatment
anti-HER2 drugs
Opis:
Introduction and objectives. Breast cancer (BC) is the most common malignancy and the leading cause of cancer death among women. About 15–20% of all BCs are HER2-positive. Proper assessment of HER2 status is crucial to choose appropriate treatment. The review summarizes data on anti-HER2 drugs used to treat HER2-positive BC and provides basic information on new agents under investigation. Brief description of the state of knowledge. Specific HER2-targeting drugs are available or are being evaluated in clinical trials. Anti-HER2 agents include: monoclonal antibodies, tyrosine kinase inhibitors, antibody-drug conjugates, bispecific antibodies, PI3K/AKT/mTOR inhibitors and heat shock protein 90 inhibitors, HER2-targeting vaccines and CDK4/6 inhibitors. The advent of anti-HER2 therapies increased the time of progression free survival and overall survival in BC patients. Results. Final analysis of the CLEOPATRA trial shows that the combination of trastuzumab, pertuzumab and taxane significantly improved outcomes in metastatic HER2-positive BC and it is currently preferred first-line treatment. The recommended second-line treatment is based on trastuzumab emtansine or on the combination of lapatinib and capecitabine. Some promising agents such as margetuximab or trastuzumab deruxtecan are still under investigation. Conclusions. Anti-HER2 directed treatment undoubtedly improves outcomes among patients with HER2-positive BC. Access to drugs such as trastuzumab, pertuzumab, lapatinib and T-DM1 improves prognosis even in patients with advanced disease. Further studies and clinical trials on novel anti-HER2 therapies are required. Nevertheless, BC treatment is becoming more effective and, hopefully, one day it may be possible to cure patients even with metastases.
Źródło:
Journal of Pre-Clinical and Clinical Research; 2020, 14, 2; 44-48
1898-2395
Pojawia się w:
Journal of Pre-Clinical and Clinical Research
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Metastatic and non-metastatic sentinel inguinofemoral lymph nodes in vulvar cancer show an increased lymphangiogenesis
Autorzy:
Piechowicz, M.
Mikos, M.
Banas, T.
Okon, K.
Pietrus, M.
Balajewicz-Nowak, M.
Szczudlik, L.
Kojs, Z.
Czerw, A.
Juszczyk, G.
Pityński, K.
Powiązania:
https://bibliotekanauki.pl/articles/2085422.pdf
Data publikacji:
2020
Wydawca:
Instytut Medycyny Wsi
Tematy:
anti-D2–40 antibody
lymphatic vessel density
immunohistochemistry
sentinel lymph node
vulvar cancer
Opis:
Introduction and objective. Lymph node involvement is a strong predictor of disease recurrence and patient survival in vulvar cancer. The aim of the study was to evaluate the feasibility of sentinel lymph node (SLN) screening, the incidence of skip metastases, and lymph node lymphangiogenesis. Materials and method. Fifty-five patients participated in this prospective, single centre study. A double SLN screening method was employed using radiocolloid (technetium-99 sulfur colloid) and 1.0% Isosulfan Blue. Immunohistochemistry, using a mouse monoclonal antibody against D2–40, was used to evaluate lymphatic vessel density (LVD). All calculations were performed using STATISTICA software v. 10 (StatSoft, USA, 2011); p<0.05 was considered significant. Results. Using both methods of SLN detection, 100% accuracy was achieved, and skip metastases were diagnosed in only one woman (1.82%). Peri-tumour median LVD was significantly increased compared with matched intra-tumour samples (p<0.001), while median LVD was significantly lower in negative, compared with positive SLN, regardless of whether matched non-SLN were negative (p<0.001) or positive (p=0.005). Metastatic SLN exhibited significantly higher median LVD compared with matched negative non-SLN (p=0.015), while no significant difference in median LVD was detected between positive SLN and matched positive non-SLN. However, negative SLN had a significantly higher median LVD compared with matched negative non-SLN (p = 0.012). Conclusions. SLN detection is a safe and feasible procedure in vulvar cancer. In patients without nodular involvement, SLN, compared with non-SLN, exhibited significantly higher median LVD, which may be an indication of its preparation to host metastases, and thus requires further investigation.
Źródło:
Annals of Agricultural and Environmental Medicine; 2020, 27, 1; 123-128
1232-1966
Pojawia się w:
Annals of Agricultural and Environmental Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Polish Consensus on Treatment of Gastric Cancer; update 2017
Autorzy:
Kulig, Jan
Wallner, Grzegorz
Drews, Michał
Frączek, Mariusz
Jeziorski, Arkadiusz
Kielan, Wojciech
Kołodziejczyk, Piotr
Nasierowska-Guttmejer, Anna
Starzyńska, Teresa
Zinkiewicz, Krzysztof
Wojtukiewicz, Marek
Skoczylas, W. Tomasz
Richter, Piotr
Krawczyk, Marek
Powiązania:
https://bibliotekanauki.pl/articles/1393313.pdf
Data publikacji:
2017
Wydawca:
Index Copernicus International
Tematy:
Gastric Cancer
Helicobacter pylori
Laparotomy
Non-steroidal anti-inflammatory drugs
Immunohistochemistry
Surgical treatment
Panendoscopy
Biopsy
Opis:
The “Polish Research on Gastric Cancer” project has been continued since 1986. The main aim of this project, which is a multicenter and interdisciplinary research, is enhancing the treatment results of gastric cancer patients by developing and promoting the use of optimal methods for diagnosis and treatment, both surgical as well as combined. One of the more important achievements of the project is the development and publication of a document named “Polish Consensus on Treatment of Patients with Gastric Cancer”, whose first version was published in 1998. Following versions were updated adequately to changing trends in the proceedings in patients with gastric cancer. A scientific symposium on “Polish Consensus on Treatment of Gastric Cancer – update 2016” was held in 3-4 June 2016 in Cracow. During the symposium a panel session was held during which all authors publicly presented the Consensus assumptions to be discussed further. Moreover, the already mentioned session was preceded by a correspondence as well as a working meeting in order to consolidate the position. It has to be underlined that the directions and guidelines included in the Consensus are not the arbitrarily assumed rules of conduct in a legal aspect and as such every doctor/team of doctors is entitled to make different decisions as long as they are beneficial to a patient with gastric cancer. The Consensus discusses as follows: a) recommended qualifications (stage of advancement, pathological, lymph node topography and the extent of lymphadenectomy, division of cancer of the gastroesophageal junction), b) rules for diagnostics including recommendations regarding endoscopic examination and clinical evaluation of the advancement stage, c) recommendations regarding surgical treatment (extent of resection, extent of lymphadenectomy, tactics of proceedings in cancer of the gastroesophageal junction), d) recommendations regarding combined treatment with chemotherapy or radiotherapy, e) place of endoscopic and less invasive surgery in the treatment of gastric cancer. This publication is a summary of the arrangements made in the panel session during the abovementioned scientific symposium in Cracow in 2016.
Źródło:
Polish Journal of Surgery; 2017, 89, 5; 59-73
0032-373X
2299-2847
Pojawia się w:
Polish Journal of Surgery
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Contemporary management and novel therapies in ovarian cancer – literature review
Autorzy:
Kotowski, Krzysztof
Przystupski, Dawid
Kwiatkowski, Stanisław
Kolasińska, Karolina
Bartosik, Weronika
Górska, Agata
Saczko, Jolanta
Baczyńska, Dagmara
Kulbacka, Julita
Powiązania:
https://bibliotekanauki.pl/articles/1162168.pdf
Data publikacji:
2018
Wydawca:
Przedsiębiorstwo Wydawnictw Naukowych Darwin / Scientific Publishing House DARWIN
Tematy:
Anti-VEGF monoclonal IgG1 antibody
Interval Cytoreductive Surgery
Interval Debuking Surgery
bevacizumab
electrochemotherapy
hormone therapy
immunotherapy
ovarian cancer
photodynamic therapy
Opis:
Ovarian cancer is characterized by an extremely poor prognosis in women with an advanced stage of this carcinoma. In United States every year 20,000 women are diagnosed with ovarian cancer. It is the fifth most frequent cause of death from cancer in females and the most common cause of death for 15 years after diagnosis in women with stage III-IV tumors. Among ovarian neoplasms the most frequent are surface epithelial-stromal tumors. Moreover, non-epithelial ovarian tumors are distinguished. This group matters 10% of patients with diagnosed ovarian tumors. Due to a huge variety of ovarian tumors, the following work focuses mainly on the current clinical treatment of the epithelial ovarian cancer. The following paper summarizes current clinical treatment of epithelial ovarian cancer, including surgical procedure, chemo- and immunotherapy including modern therapeutic approaches.
Źródło:
World Scientific News; 2018, 111; 51-63
2392-2192
Pojawia się w:
World Scientific News
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-14 z 14

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies